NCT05354375View on ClinicalTrials.gov

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Immunotherapy
Interventions
BIOLOGICAL

CAR-T cell immunotherapy

This CAR-T cell immunotherapy with a novel specific Chimeric antigen receptor aiming at PSMA.

Trial Locations (1)

221000

RECRUITING

Affiliated Hospital of Xuzhou Medical University, Xuzhou

All Listed Sponsors
collaborator

Xuzhou Medical University

OTHER

lead

The Affiliated Hospital of Xuzhou Medical University

OTHER